Trials / Conditions / RET-altered Non Small Cell Lung Cancer
RET-altered Non Small Cell Lung Cancer
3 registered clinical trials studyying RET-altered Non Small Cell Lung Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | A Study of TY-1091 in Patients With Advanced Solid Tumors NCT05675605 | TYK Medicines, Inc | Phase 1 / Phase 2 |
| Recruiting | Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities NCT04683250 | Taiho Pharmaceutical Co., Ltd. | Phase 1 / Phase 2 |
| Completed | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Can NCT03037385 | Hoffmann-La Roche | Phase 1 / Phase 2 |